8-KThe WireRoutine
Reg FD Disclosure
Filed Jan 5, 2022 · 4y ago · Accession 0001564590-22-000413
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Damora Therapeutics, Inc.
- Ticker
- DMRA
- CIK
- 1800315
- Form type
- 8-K
- Filing date
- Jan 5, 2022
- Report date
- Jan 5, 2022
- Document
- glto-8k_20220105.htm
- Size
- 8.3 MB